Unknown

Dataset Information

0

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.


ABSTRACT: Although the field of pharmacogenetics has existed for decades, practioners have been slow to implement pharmacogenetic testing in clinical care. Numerous publications describe the barriers to clinical implementation of pharmacogenetics. Recently, several freely available resources have been developed to help address these barriers. In this review, we discuss current programs that use preemptive genotyping to optimize the pharmacotherapy of patients. Array-based preemptive testing includes a large number of relevant pharmacogenes that impact multiple high-risk drugs. Using a preemptive approach allows genotyping results to be available prior to any prescribing decision so that genomic variation may be considered as an inherent patient characteristic in the planning of therapy. This review describes the common elements among programs that have implemented preemptive genotyping and highlights key processes for implementation, including clinical decision support.

SUBMITTER: Dunnenberger HM 

PROVIDER: S-EPMC4607278 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.

Dunnenberger Henry M HM   Crews Kristine R KR   Hoffman James M JM   Caudle Kelly E KE   Broeckel Ulrich U   Howard Scott C SC   Hunkler Robert J RJ   Klein Teri E TE   Evans William E WE   Relling Mary V MV  

Annual review of pharmacology and toxicology 20141002


Although the field of pharmacogenetics has existed for decades, practioners have been slow to implement pharmacogenetic testing in clinical care. Numerous publications describe the barriers to clinical implementation of pharmacogenetics. Recently, several freely available resources have been developed to help address these barriers. In this review, we discuss current programs that use preemptive genotyping to optimize the pharmacotherapy of patients. Array-based preemptive testing includes a lar  ...[more]

Similar Datasets

| S-EPMC10879811 | biostudies-literature
| S-EPMC6523655 | biostudies-literature
| S-EPMC5546947 | biostudies-literature
| S-EPMC7771612 | biostudies-literature
| S-EPMC4763391 | biostudies-literature
| S-EPMC4039055 | biostudies-literature
| S-EPMC9333201 | biostudies-literature
| S-EPMC3785311 | biostudies-literature
| S-EPMC6313650 | biostudies-literature